Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Nucleic Acids Res ; 50(1): e2, 2022 01 11.
Article in English | MEDLINE | ID: mdl-34581823

ABSTRACT

Template-switching reverse transcription is widely used in RNA sequencing for low-input and low-quality samples, including RNA from single cells or formalin-fixed paraffin-embedded (FFPE) tissues. Previously, we identified the native eukaryotic mRNA 5' cap as a key structural element for enhancing template switching efficiency. Here, we introduce CapTS-seq, a new strategy for sequencing small RNAs that combines chemical capping and template switching. We probed a variety of non-native synthetic cap structures and found that an unmethylated guanosine triphosphate cap led to the lowest bias and highest efficiency for template switching. Through cross-examination of different nucleotides at the cap position, our data provided unequivocal evidence that the 5' cap acts as a template for the first nucleotide in reverse transcriptase-mediated post-templated addition to the emerging cDNA-a key feature to propel template switching. We deployed CapTS-seq for sequencing synthetic miRNAs, human total brain and liver FFPE RNA, and demonstrated that it consistently improves library quality for miRNAs in comparison with a gold standard template switching-based small RNA-seq kit.


Subject(s)
RNA Caps/metabolism , RNA/analysis , Sequence Analysis, RNA/methods , Humans , Tissue Fixation
2.
Front Cell Infect Microbiol ; 11: 687019, 2021.
Article in English | MEDLINE | ID: mdl-34195101

ABSTRACT

Plasmodium is a genus of apicomplexan parasites which replicate in the liver before causing malaria. Plasmodium vivax can also persist in the liver as dormant hypnozoites and cause clinical relapse upon activation, but the molecular mechanisms leading to activation have yet to be discovered. In this study, we use high-resolution microscopy to characterize temporal changes of the P. vivax liver stage tubovesicular network (TVN), a parasitophorous vacuole membrane (PVM)-derived network within the host cytosol. We observe extended membrane clusters, tubules, and TVN-derived vesicles present throughout P. vivax liver stage development. Additionally, we demonstrate an unexpected presence of the TVN in hypnozoites and observe some association of this network to host nuclei. We also reveal that the host water and solute channel aquaporin-3 (AQP3) associates with TVN-derived vesicles and extended membrane clusters. AQP3 has been previously shown to localize to the PVM of P. vivax hypnozoites and liver schizonts but has not yet been shown in association to the TVN. Our results highlight host-parasite interactions occur in both dormant and replicating liver stage P. vivax forms and implicate AQP3 function during this time. Together, these findings enhance our understanding of P. vivax liver stage biology through characterization of the TVN with an emphasis on the presence of this network in dormant hypnozoites.


Subject(s)
Malaria, Vivax , Plasmodium , Animals , Liver , Plasmodium vivax , Schizonts
3.
Cell Chem Biol ; 27(6): 719-727.e5, 2020 06 18.
Article in English | MEDLINE | ID: mdl-32330444

ABSTRACT

Plasmodium vivax infects hepatocytes to form schizonts that cause blood infection, or dormant hypnozoites that can persist for months in the liver before leading to relapsing blood infections. The molecular processes that drive P. vivax schizont and hypnozoite survival remain largely unknown, but they likely involve a rich network of host-pathogen interactions, including those occurring at the host-parasite interface, the parasitophorous vacuole membrane (PVM). Using a recently developed P. vivax liver-stage model system we demonstrate that host aquaporin-3 (AQP3) localizes to the PVM of schizonts and hypnozoites within 5 days after invasion. This recruitment is also observed in P. vivax-infected reticulocytes. Chemical treatment with the AQP3 inhibitor auphen reduces P. vivax liver hypnozoite and schizont burden, and inhibits P. vivax asexual blood-stage growth. These findings reveal a role for AQP3 in P. vivax liver and blood stages and suggest that the protein may be targeted for therapeutic treatment.


Subject(s)
Aquaporin 3/metabolism , Liver/metabolism , Malaria, Vivax/metabolism , Plasmodium vivax/metabolism , Cells, Cultured , Humans , Liver/drug effects , Liver/parasitology , Malaria, Vivax/drug therapy , Malaria, Vivax/parasitology , Plasmodium vivax/isolation & purification
4.
mBio ; 11(1)2020 02 04.
Article in English | MEDLINE | ID: mdl-32019802

ABSTRACT

The apicomplexan parasites Plasmodium spp. are the causative agents of malaria, a disease that poses a significant global health burden. Plasmodium spp. initiate infection of the human host by transforming and replicating within hepatocytes. This liver stage (LS) is poorly understood compared to other Plasmodium life stages, which has hindered our ability to target these parasites for disease prevention. We conducted an extensive transcriptome sequencing (RNA-Seq) analysis throughout the Plasmodium berghei LS, covering as early as 2 h postinfection (hpi) and extending to 48 hpi. Our data revealed that hundreds of genes are differentially expressed at 2 hpi and that multiple genes shown to be important for later infection are upregulated as early as 12 hpi. Using hierarchical clustering along with coexpression analysis, we identified clusters functionally enriched for important liver-stage processes such as interactions with the host cell and redox homeostasis. Furthermore, some of these clusters were highly correlated to the expression of ApiAP2 transcription factors, while showing enrichment of mostly uncharacterized DNA binding motifs. This finding indicates potential LS targets for these transcription factors, while also hinting at alternative uncharacterized DNA binding motifs and transcription factors during this stage. Our work presents a window into the previously undescribed transcriptome of Plasmodium upon host hepatocyte infection to enable a comprehensive view of the parasite's LS. These findings also provide a blueprint for future studies that extend hypotheses concerning LS gene function in P. berghei to human-infective Plasmodium parasites.IMPORTANCE The LS of Plasmodium infection is an asymptomatic yet necessary stage for producing blood-infective parasites, the causative agents of malaria. Blocking the liver stage of the life cycle can prevent clinical malaria, but relatively less is known about the parasite's biology at this stage. Using the rodent model P. berghei, we investigated whole-transcriptome changes occurring as early as 2 hpi of hepatocytes. The transcriptional profiles of early time points (2, 4, 12, and 18 hpi) have not been accessible before due to the technical challenges associated with liver-stage infections. Our data now provide insights into these early parasite fluxes that may facilitate establishment of infection, transformation, and replication in the liver.


Subject(s)
Gene Expression Profiling , Hepatocytes/parasitology , Liver/parasitology , Malaria/parasitology , Plasmodium berghei/genetics , Hep G2 Cells , Host-Parasite Interactions/genetics , Humans , Life Cycle Stages , Plasmodium berghei/physiology , Protozoan Proteins/genetics , RNA-Seq , Sporozoites/genetics , Sporozoites/physiology
5.
Cell Chem Biol ; 26(9): 1253-1262.e5, 2019 09 19.
Article in English | MEDLINE | ID: mdl-31257182

ABSTRACT

Plasmodium parasites undergo an obligatory and asymptomatic developmental stage within the liver before infecting red blood cells to cause malaria. The hijacked host pathways critical to parasite infection during this hepatic phase remain poorly understood. Here, we implemented a forward genetic screen to identify over 100 host factors within the human druggable genome that are critical to P. berghei infection in hepatoma cells. Notably, we found knockdown of genes involved in protein trafficking pathways to be detrimental to parasite infection. The disruption of protein trafficking modulators, including COPB2 and GGA1, decreases P. berghei parasite size, and an immunofluorescence study suggests that these proteins are recruited to the Plasmodium parasitophorous vacuole in infected hepatocytes. These findings reveal that various host intracellular protein trafficking pathways are subverted by Plasmodium parasites during the liver stage and provide new insights into their manipulation for growth and development.


Subject(s)
Malaria/drug therapy , Malaria/genetics , Plasmodium berghei/drug effects , Adaptor Proteins, Vesicular Transport/genetics , Animals , Carcinoma, Hepatocellular/genetics , Cell Line , Coatomer Protein/genetics , Communicable Diseases , Hep G2 Cells , Hepatocytes/metabolism , Humans , Liver/metabolism , Liver/parasitology , Mice , Parasites , Plasmodium/metabolism , Plasmodium berghei/genetics , Plasmodium berghei/metabolism , Protein Transport/genetics
6.
PLoS One ; 14(2): e0212005, 2019.
Article in English | MEDLINE | ID: mdl-30794564

ABSTRACT

Canonical and non-canonical Wnt signaling, as well as the Pax/Six gene network, are involved in patterning the freshwater sponge aquiferous system. Using computational approaches to identify transcription factor binding motifs in a freshwater sponge genome, we located putative PaxB binding sites near a Secreted Frizzled Related Protein (SFRP) gene in Ephydatia muelleri. EmSFRP is expressed throughout development, but with highest levels in juvenile sponges. In situ hybridization and antibody staining show EmSFRP expression throughout the pinacoderm and choanoderm in a subpopulation of amoeboid cells that may be differentiating archeocytes. Knockdown of EmSFRP leads to ectopic oscula formation during development, suggesting that EmSFRP acts as an antagonist of Wnt signaling in E. muelleri. Our findings support a hypothesis that regulation of the Wnt pathway by the Pax/Six network as well as the role of Wnt signaling in body plan morphogenesis was established before sponges diverged from the rest of the metazoans.


Subject(s)
Intracellular Signaling Peptides and Proteins/metabolism , Otx Transcription Factors/metabolism , Porifera/growth & development , Animals , Binding Sites , Body Patterning , Computational Biology , Fresh Water , Gene Expression Regulation, Developmental , Gene Knockdown Techniques , Intracellular Signaling Peptides and Proteins/chemistry , Intracellular Signaling Peptides and Proteins/genetics , Porifera/genetics , Porifera/metabolism , Wnt Signaling Pathway
7.
ChemMedChem ; 13(23): 2479-2483, 2018 12 06.
Article in English | MEDLINE | ID: mdl-30328274

ABSTRACT

An in silico screen of 350 000 commercially available compounds was conducted with an unbiased approach to identify potential malaria inhibitors that bind to the Plasmodium falciparum protein kinase 5 (PfPK5) ATP-binding site. PfPK5 is a cyclin-dependent kinase-like protein with high sequence similarity to human cyclin-dependent kinase 2 (HsCDK2), but its precise role in cell-cycle regulation remains unclear. After two-dimensional fingerprinting of the top scoring compounds, 182 candidates were prioritized for biochemical testing based on their structural diversity. Evaluation of these compounds demonstrated that 135 bound to PfPK5 to a similar degree or better than known PfPK5 inhibitors, confirming that the library was enriched with PfPK5-binding compounds. A previously reported triazolodiamine HsCDK2 inhibitor and the screening hit 4-methylumbelliferone were each selected for an analogue study. The results of this study highlight the difficult balance between optimization of PfPK5 affinity and binding selectivity for PfPK5 over its closest human homologue HsCDK2. Our approach enabled the discovery of several new PfPK5-binding compounds from a modest screening campaign and revealed the first scaffold to have improved PfPK5/HsCDK2 selectivity. These steps are critical for the development of PfPK5-targeting probes for functional studies and antimalarials with decreased risks of host toxicity.


Subject(s)
Antimalarials/chemistry , Antimalarials/pharmacology , Cyclins/antagonists & inhibitors , Plasmodium falciparum/drug effects , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/pharmacology , Protozoan Proteins/antagonists & inhibitors , Computer Simulation , Cyclins/metabolism , Drug Discovery , Hep G2 Cells , Humans , Malaria, Falciparum/drug therapy , Malaria, Falciparum/parasitology , Plasmodium falciparum/metabolism , Protozoan Proteins/metabolism , Structure-Activity Relationship
8.
PLoS Pathog ; 14(5): e1007057, 2018 05.
Article in English | MEDLINE | ID: mdl-29775485

ABSTRACT

Within the liver a single Plasmodium parasite transforms into thousands of blood-infective forms to cause malaria. Here, we use RNA-sequencing to identify host genes that are upregulated upon Plasmodium berghei infection of hepatocytes with the hypothesis that host pathways are hijacked to benefit parasite development. We found that expression of aquaporin-3 (AQP3), a water and glycerol channel, is significantly induced in Plasmodium-infected hepatocytes compared to uninfected cells. This aquaglyceroporin localizes to the parasitophorous vacuole membrane, the compartmental interface between the host and pathogen, with a temporal pattern that correlates with the parasite's expansion in the liver. Depletion or elimination of host AQP3 expression significantly reduces P. berghei parasite burden during the liver stage and chemical disruption by a known AQP3 inhibitor, auphen, reduces P. falciparum asexual blood stage and P. berghei liver stage parasite load. Further use of this inhibitor as a chemical probe suggests that AQP3-mediated nutrient transport is an important function for parasite development. This study reveals a previously unknown potential route for host-dependent nutrient acquisition by Plasmodium which was discovered by mapping the transcriptional changes that occur in hepatocytes throughout P. berghei infection. The dataset reported may be leveraged to identify additional host factors that are essential for Plasmodium liver stage infection and highlights Plasmodium's dependence on host factors within hepatocytes.


Subject(s)
Aquaporin 3/metabolism , Plasmodium berghei/metabolism , Animals , Aquaporin 3/physiology , Hep G2 Cells , Hepatocytes/metabolism , Hepatocytes/parasitology , Humans , Liver/metabolism , Liver/parasitology , Liver Diseases , Malaria/parasitology , Mice , Parasites/metabolism , Plasmodium berghei/genetics , Plasmodium berghei/parasitology , Protozoan Proteins/metabolism , Sequence Analysis, RNA/methods , Sporozoites/metabolism , Vacuoles/metabolism
9.
BMC Evol Biol ; 18(1): 12, 2018 02 02.
Article in English | MEDLINE | ID: mdl-29394881

ABSTRACT

BACKGROUND: The Wnt signaling pathway is uniquely metazoan and used in many processes during development, including the formation of polarity and body axes. In sponges, one of the earliest diverging animal groups, Wnt pathway genes have diverse expression patterns in different groups including along the anterior-posterior axis of two sponge larvae, and in the osculum and ostia of others. We studied the function of Wnt signaling and body polarity formation through expression, knockdown, and larval manipulation in several freshwater sponge species. RESULTS: Sponge Wnts fall into sponge-specific and sponge-class specific subfamilies of Wnt proteins. Notably Wnt genes were not found in transcriptomes of the glass sponge Aphrocallistes vastus. Wnt and its signaling genes were expressed in archaeocytes of the mesohyl throughout developing freshwater sponges. Osculum formation was enhanced by GSK3 knockdown, and Wnt antagonists inhibited both osculum development and regeneration. Using dye tracking we found that the posterior poles of freshwater sponge larvae give rise to tissue that will form the osculum following metamorphosis. CONCLUSIONS: Together the data indicate that while components of canonical Wnt signaling may be used in development and maintenance of osculum tissue, it is likely that Wnt signaling itself occurs between individual cells rather than whole tissues or structures in freshwater sponges.


Subject(s)
Fresh Water , Porifera/metabolism , Wnt Signaling Pathway , Animals , Gene Expression Regulation , Glycogen Synthase Kinase 3/genetics , Larva/genetics , Phylogeny , Porifera/genetics , RNA Interference , Wnt Proteins/genetics , Wnt Proteins/metabolism , Wnt Signaling Pathway/genetics , beta Catenin/metabolism
10.
Article in English | MEDLINE | ID: mdl-29339390

ABSTRACT

Malaria remains a global health burden partly due to Plasmodium parasite resistance to first-line therapeutics. The molecular chaperone heat shock protein 90 (Hsp90) has emerged as an essential protein for blood-stage Plasmodium parasites, but details about its function during malaria's elusive liver stage are unclear. We used target-based screens to identify compounds that bind to Plasmodium falciparum and human Hsp90, which revealed insights into chemotypes with species-selective binding. Using cell-based malaria assays, we demonstrate that all identified Hsp90-binding compounds are liver- and blood-stage Plasmodium inhibitors. Additionally, the Hsp90 inhibitor SNX-0723 in combination with the phosphatidylinositol 3-kinase inhibitor PIK-75 synergistically reduces the liver-stage parasite load. Time course inhibition studies with the Hsp90 inhibitors and expression analysis support a role for Plasmodium Hsp90 in late-liver-stage parasite development. Our results suggest that Plasmodium Hsp90 is essential to liver- and blood-stage parasite infections and highlight an attractive route for development of species-selective PfHsp90 inhibitors that may act synergistically in combination therapies to prevent and treat malaria.


Subject(s)
Antimalarials/therapeutic use , HSP90 Heat-Shock Proteins/antagonists & inhibitors , Benzamides/therapeutic use , HSP90 Heat-Shock Proteins/metabolism , Host-Pathogen Interactions , Humans , Hydrazones/therapeutic use , Indoles/therapeutic use , Malaria/drug therapy , Malaria/metabolism , Plasmodium falciparum/drug effects , Plasmodium falciparum/metabolism , Plasmodium falciparum/pathogenicity , Sulfonamides/therapeutic use , ortho-Aminobenzoates/therapeutic use
11.
J Clin Invest ; 126(6): 2013-20, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27249674

ABSTRACT

Malaria remains a global public health threat, with half of the world's population at risk. Despite numerous efforts in the past decade to develop new antimalarial drugs to surmount increasing resistance to common therapies, challenges remain in the expansion of the current antimalarial arsenal for the elimination of this disease. The requirement of prophylactic and radical cure activities for the next generation of antimalarial drugs demands that new research models be developed to support the investigation of the elusive liver stage of the malaria parasite. In this Review, we revisit current antimalarial therapies and discuss recent advances for in vitro and in vivo malaria research models of the liver stage and their importance in probing parasite biology and the discovery of novel drug candidates.


Subject(s)
Antimalarials/therapeutic use , Malaria/drug therapy , Animals , Drug Design , Drug Discovery , Drug Resistance , Humans , Liver/parasitology , Malaria/parasitology , Malaria/prevention & control , Models, Biological , Plasmodium/drug effects , Plasmodium/growth & development
12.
BMC Biotechnol ; 11: 67, 2011 Jun 16.
Article in English | MEDLINE | ID: mdl-21679422

ABSTRACT

BACKGROUND: The marine sponge Tethya wilhelma and the freshwater sponge Ephydatia muelleri are emerging model organisms to study evolution, gene regulation, development, and physiology in non-bilaterian animal systems. Thus far, functional methods (i.e., loss or gain of function) for these organisms have not been available. RESULTS: We show that soaking developing freshwater sponges in double-stranded RNA and/or feeding marine and freshwater sponges bacteria expressing double-stranded RNA can lead to RNA interference and reduction of targeted transcript levels. These methods, first utilized in C. elegans, have been adapted for the development and feeding style of easily cultured marine and freshwater poriferans. We demonstrate phenotypic changes result from 'knocking down' expression of the actin gene. CONCLUSION: This technique provides an easy, efficient loss-of-function manipulation for developmental and gene regulatory studies in these important non-bilaterian animals.


Subject(s)
Escherichia coli/genetics , Gene Knockdown Techniques/methods , Porifera/genetics , RNA Interference , RNA, Double-Stranded/genetics , Actins/analysis , Actins/genetics , Actins/metabolism , Animals , Aquatic Organisms/cytology , Aquatic Organisms/drug effects , Aquatic Organisms/genetics , Escherichia coli/metabolism , Feeding Behavior , Fresh Water , Gene Expression Profiling , Histocytochemistry , Microscopy, Confocal , Porifera/cytology , Porifera/drug effects , RNA, Double-Stranded/administration & dosage , RNA, Double-Stranded/biosynthesis , Seawater
SELECTION OF CITATIONS
SEARCH DETAIL
...